{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:12:41Z","timestamp":1791403961831,"version":"4.3.3"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiology &amp; Behavior"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.physbeh.2010.09.002","type":"journal-article","created":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T08:33:30Z","timestamp":1283934810000},"page":"105-109","source":"Crossref","is-referenced-by-count":14,"title":["The autonomic stress-induced hyperthermia response is not enhanced by several anxiogenic drugs"],"prefix":"10.1016","volume":"102","author":[{"given":"Lotte C.","family":"Houtepen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle P.","family":"Peterse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen G.C.","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berend","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiaan H.","family":"Vinkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.physbeh.2010.09.002_bb0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biopsycho.2005.08.009","article-title":"An autonomic flexibility-neurovisceral integration model of anxiety and cardiac vagal tone","volume":"74","author":"Friedman","year":"2007","journal-title":"Biol Psychol"},{"issue":"6","key":"10.1016\/j.physbeh.2010.09.002_bb0010","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00008877-199312000-00009","article-title":"The free-exploratory paradigm: an effective method for measuring neophobic behaviour in mice and testing potential neophobia-reducing drugs","volume":"4","author":"Griebel","year":"1993","journal-title":"Behav Pharmacol"},{"issue":"4","key":"10.1016\/j.physbeh.2010.09.002_bb0015","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1527-3458.2007.00025.x","article-title":"Pharmacology of the beta-carboline FG-7, 142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects","volume":"13","author":"Evans","year":"2007","journal-title":"CNS Drug Rev"},{"issue":"3","key":"10.1016\/j.physbeh.2010.09.002_bb0020","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1124\/jpet.106.113357","article-title":"5-Hydroxytryptamine2C receptor contribution to m-chlorophenylpiperazine and N-methyl-beta-carboline-3-carboxamide-induced anxiety-like behavior and limbic brain activation","volume":"320","author":"Hackler","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.physbeh.2010.09.002_bb0025","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00213-009-1475-x","article-title":"Effects of yohimbine and hydrocortisone on panic symptoms, autonomic responses, and attention to threat in healthy adults","volume":"204","author":"Vasa","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.physbeh.2010.09.002_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00221-008-1337-5","article-title":"Organization of brain somatomotor-sympathetic circuits","volume":"187","author":"Kerman","year":"2008","journal-title":"Exp Brain Res"},{"issue":"2","key":"10.1016\/j.physbeh.2010.09.002_bb0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0166-4328(97)00198-8","article-title":"Behavioural profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour","volume":"94","author":"Liebsch","year":"1998","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.physbeh.2010.09.002_bb0040","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The Open-Field Test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol Bull"},{"issue":"1\u20133","key":"10.1016\/j.physbeh.2010.09.002_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.physbeh.2010.09.002_bb0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02247358","article-title":"5HT drugs in animal models of anxiety","volume":"112","author":"Handley","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.physbeh.2010.09.002_bb0055","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF00212837","article-title":"Anxiogenic properties of beta-CCE and FG 7142: a review of promises and pitfalls","volume":"94","author":"Thiebot","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.physbeh.2010.09.002_bb0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0165-1781(97)00041-3","article-title":"Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls","volume":"71","author":"Gurguis","year":"1997","journal-title":"Psychiatry Res"},{"issue":"2","key":"10.1016\/j.physbeh.2010.09.002_bb0065","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0149-7634(98)00024-4","article-title":"The elevated T-maze as an experimental model of anxiety","volume":"23","author":"Graeff","year":"1998","journal-title":"Neurosci Biobehav Rev"},{"issue":"2\u20133","key":"10.1016\/j.physbeh.2010.09.002_bb0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejphar.2008.02.097","article-title":"Translational aspects of pharmacological research into anxiety disorders: the stress-induced hyperthermia (SIH) paradigm","volume":"585","author":"Vinkers","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.physbeh.2010.09.002_bb0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0014-2999(95)00520-X","article-title":"Stress-induced hyperthermia as a putative anxiety model","volume":"294","author":"Zethof","year":"1995","journal-title":"Eur J Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.physbeh.2010.09.002_bb0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01244453","article-title":"Effect of psychotomimetics and some putative anxiolytics on stress-induced hyperthermia","volume":"83","author":"Lecci","year":"1991","journal-title":"J Neural Transm Gen Sect"},{"issue":"3","key":"10.1016\/j.physbeh.2010.09.002_bb0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01272765","article-title":"Effect of serotoninergic drugs on stress-induced hyperthermia (SIH) in mice","volume":"82","author":"Lecci","year":"1990","journal-title":"J Neural Transm Gen Sect"},{"issue":"1\u20133","key":"10.1016\/j.physbeh.2010.09.002_bb0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(03)01326-8","article-title":"Stress-induced hyperthermia and anxiety: pharmacological validation","volume":"463","author":"Olivier","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.physbeh.2010.09.002_bb0095","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0014-2999(00)00012-1","article-title":"Characterization of D-fenfluramine-induced hypothermia: evidence for multiple sites of action","volume":"390","author":"Cryan","year":"2000","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.physbeh.2010.09.002_bb0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF02246643","article-title":"Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors","volume":"123","author":"Mazzola-Pomietto","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.physbeh.2010.09.002_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0028-3908(85)90097-8","article-title":"A benzodiazepine agonist and contragonist have hypothermic effects in rodents","volume":"24","author":"Taylor","year":"1985","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.physbeh.2010.09.002_bb0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF00442817","article-title":"Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat","volume":"99","author":"File","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"issue":"1\u20133","key":"10.1016\/j.physbeh.2010.09.002_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(03)01273-1","article-title":"A review of 25years of the social interaction test","volume":"463","author":"File","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.physbeh.2010.09.002_bb0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0091-3057(97)00564-9","article-title":"The anxiogenic agents, yohimbine and FG 7142, disrupt the noradrenergic response to novelty","volume":"60","author":"Mason","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.physbeh.2010.09.002_bb0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biopsych.2004.10.006","article-title":"Anxiogenic treatments do not increase fear-potentiated startle in mice","volume":"57","author":"Risbrough","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.physbeh.2010.09.002_bb0130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1037\/0021-843X.104.1.224","article-title":"Psychophysiological differences between subgroups of social phobia","volume":"104","author":"Hofmann","year":"1995","journal-title":"J Abnorm Psychol"},{"issue":"2","key":"10.1016\/j.physbeh.2010.09.002_bb0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0887-6185(02)00197-4","article-title":"Embarrassment and social phobia: the role of parasympathetic activation","volume":"17","author":"Gerlach","year":"2003","journal-title":"J Anxiety Disord"},{"issue":"2","key":"10.1016\/j.physbeh.2010.09.002_bb0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0005-7967(85)90019-1","article-title":"Physiological, cognitive and behavioral aspects of social anxiety","volume":"23","author":"Beidel","year":"1985","journal-title":"Behav Res Ther"},{"issue":"9","key":"10.1016\/j.physbeh.2010.09.002_bb0145","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.61.9.913","article-title":"Somatic symptoms and physiologic responses in generalized anxiety disorder and panic disorder: an ambulatory monitor study","volume":"61","author":"Hoehn-Saric","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"10.1016\/j.physbeh.2010.09.002_bb0150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.euroneuro.2004.01.001","article-title":"Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine in patients with panic disorder and controls","volume":"14","author":"van der Wee","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"10.1016\/j.physbeh.2010.09.002_bb0155","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.euroneuro.2007.03.005","article-title":"Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controls","volume":"17","author":"Van Veen","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.physbeh.2010.09.002_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(84)90537-7","article-title":"Regulation of body temperature and nociception induced by non-noxious stress in rat","volume":"297","author":"Vidal","year":"1984","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.physbeh.2010.09.002_bb0165","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.physbeh.2009.07.004","article-title":"Sex differences in stress-induced hyperthermia in rats: restraint versus confinement","volume":"98","author":"McGivern","year":"2009","journal-title":"Physiol Behav"},{"issue":"1","key":"10.1016\/j.physbeh.2010.09.002_bb0170","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/sj.npp.1300006","article-title":"Central serotonergic effects of m-chlorophenylpiperazine (mCPP) among normal control adolescents","volume":"28","author":"Ghaziuddin","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.physbeh.2010.09.002_bb0175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s002130050406","article-title":"SSRI treatment decreases prolactin and hyperthermic responses to mCPP","volume":"133","author":"Quested","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.physbeh.2010.09.002_bb0180","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0091-3057(95)00122-D","article-title":"5-HT1A and 5-HT2 receptors mediate hypo- and hyperthermic effects of tryptophan in pargyline-pretreated rats","volume":"52","author":"Abdel-Fattah","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.physbeh.2010.09.002_bb0185","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0022-3565(24)37161-7","article-title":"Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites","volume":"283","author":"Owens","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.physbeh.2010.09.002_bb0190","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0893-133X(00)00221-9","article-title":"1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain","volume":"24","author":"Baumann","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2010.09.002_bb0195","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1749-6632.1998.tb10185.x","article-title":"Pharmacological characterization of the constitutively activated state of the serotonin 5-HT2C receptor","volume":"861","author":"Herrick-Davis","year":"1998","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"10.1016\/j.physbeh.2010.09.002_bb0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1098-2396(200002)35:2<79::AID-SYN1>3.0.CO;2-X","article-title":"Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states","volume":"35","author":"Millan","year":"2000","journal-title":"Synapse"},{"issue":"2\u20133","key":"10.1016\/j.physbeh.2010.09.002_bb0205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0091-3057(94)00374-R","article-title":"Temperature-dependent effects of alpha-adrenergic agonists and antagonists in the cold","volume":"51","author":"Carlisle","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.physbeh.2010.09.002_bb0210","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0014-2999(91)90823-9","article-title":"Comparison of the effects of benzodiazepine and beta-carboline inverse agonists on body temperature in mice","volume":"205","author":"Jackson","year":"1991","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.physbeh.2010.09.002_bb0215","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1476-5381.1986.tb10230.x","article-title":"The effects of drugs acting at the GABAA-receptor\/ionophore after chemical kindling with the benzodiazepine receptor ligand FG 7142","volume":"88","author":"Little","year":"1986","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.physbeh.2010.09.002_bb0220","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0031-9384(85)90145-3","article-title":"The effects of putative anxiogenic compounds (FG 7142, CGS 8216 and Ro 15-1788) on the rat corticosterone response","volume":"35","author":"Pellow","year":"1985","journal-title":"Physiol Behav"},{"issue":"4","key":"10.1016\/j.physbeh.2010.09.002_bb0225","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0091-3057(01)00706-7","article-title":"Alteration in 5-hydroxytryptamine agonist-induced behaviour following a corticosterone implant in adult rats","volume":"71","author":"Fone","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.physbeh.2010.09.002_bb0230","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0091-3057(89)90225-6","article-title":"Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites","volume":"32","author":"Johnston","year":"1989","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.physbeh.2010.09.002_bb0235","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00423061","article-title":"Behavioural effects of yohimbine administered intraventricularly in the rat","volume":"33","author":"Zebrowska-Lupina","year":"1973","journal-title":"Psychopharmacologia"},{"issue":"7","key":"10.1016\/j.physbeh.2010.09.002_bb0240","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.pnpbp.2010.07.012","article-title":"Multiple anxiogenic drugs recruit a parvalbumin-containing subpopulation of GABAergic interneurons in the basolateral amygdala.","volume":"34","author":"Hale","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.physbeh.2010.09.002_bb0245","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neuroscience.2005.03.025","article-title":"Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs","volume":"133","author":"Abrams","year":"2005","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.physbeh.2010.09.002_bb0250","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-3223(02)01574-3","article-title":"Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs","volume":"53","author":"Singewald","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2010.09.002_bb0255","article-title":"Dorsomedial hypothalamus mediates autonomic, neuroendocrine, and locomotor responses evoked from the medial preoptic area","author":"Hunt","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"10.1016\/j.physbeh.2010.09.002_bb0260","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.npp.1300007","article-title":"Neural activation profile elicited by cues associated with the anxiogenic drug yohimbine differs from that observed for reward-paired cues","volume":"28","author":"Schroeder","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.physbeh.2010.09.002_bb0265","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbr.2006.08.040","article-title":"Intrathecal administration of yohimbine impairs locomotion in intact rats","volume":"175","author":"Majczynski","year":"2006","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.physbeh.2010.09.002_bb0270","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neuropharm.2009.05.011","article-title":"Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice","volume":"57","author":"Fletcher","year":"2009","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.physbeh.2010.09.002_bb0275","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/07420529908998718","article-title":"Forced desynchrony of circadian rhythms of body temperature and activity in rats","volume":"16","author":"Strijkstra","year":"1999","journal-title":"Chronobiol Int"}],"container-title":["Physiology &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938410003185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938410003185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:54:02Z","timestamp":1740502442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938410003185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0031938410003185"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2010.09.002","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}